Skip to main content
Back to News

News From Around the System

Optical coherence tomography has potential to treat port-wine birthmarks

UCI Health — September 3, 2024

IN THE NEWS: A new study led by UC Irvine researchers found that while optical coherence tomography (OCT) could potentially guide port-wine birthmark treatment, the technology has a long way to go before it can be used in patient care. Port-wine birthmarks are reddish-purple skin discolorations caused by a concentration…

New Hope for Progressive Supranuclear Palsy with Innovative Trial

UCSF Health — September 2, 2024

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.

New Study: Can Your Phone and AI Track Parkinson’s Progression?

UCSF Health — September 1, 2024

A new video-based symptom assessment system for Parkinson’s Disease that is enabled by machine learning represents a potential solution to the challenge of assessing Parkinson’s Disease progression in a quantifiable way.

UCI Health chief procurement officer recognized as a supply chain leader to know

UCI Health — August 29, 2024

IN THE NEWS: As chief procurement officer at UCI Health, Susanna Rustad aligns innovations with the clinical needs of the academic health system for the benefit of patients. Rustad’s work has been recognized by Becker’s Hospital Review, which named her of one of the 2024 supply chain leaders to know…

Ketamine use requires careful monitoring, says UCI Health psychiatrist

UCI Health — August 29, 2024

IN THE NEWS: While ketamine is an effective therapy for treatment-resistant depression, it carries the potential to become addictive. It can even be fatal; actor Matthew Perry died of an overdose of the drug in October 2023. UCI Health psychiatrist Dr. Robert McCarron spoke to the Los Angeles Times about…

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts